ClinicalTrials.gg
Not yet recruitingNCT07588542Updated Oct 9, 2026

PACU Discharge Readiness

An interventional study of custom-created apps, neuropsychological testing, and clinical assessments in Patient Discharge, Neurocognition and Baseline, sponsored by University of Illinois at Chicago. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-09.

Sponsored by University of Illinois at Chicago · Not applicable, Interventional, and Health services research

How we know

Updated Oct 9, 2026Start date movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
1,000
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The use of custom-created apps, neuropsychological testing, and clinical assessments will be evaluated as tools for determining the appropriateness of PACU discharge to home.

02

Conditions studied

  • Patient Discharge
  • Neurocognition
  • Baseline
03

In context

Lead sponsor

University of Illinois at Chicago is the lead sponsor of 496 studies on the registry; 115 are open to participants now.

Of its 32 completed or terminated interventional studies of FDA-regulated products, 19 (59%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • The individuals will be identified from the operating room (OR) schedule and approached in the pre-operative area (or earlier, when possible).
  • Adult patients (18 years or older) listed for surgery and a planned 23-hour admission will be eligible for enrollment in this study.
  • Subjects must be fluent in English and not have confounding sensory or neurological limitations to participation

Exclusion criteria

Exclusion Criteria:

  • Members of vulnerable populations or adults unable to consent will be included in this study.
  • Subjects that do not speak English
  • Subjects with neurological limirations
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
1,000 participants (estimated)

Study arms

  • Experimental
    Neuro Assessment Group

    Diagnostic Test: custom-created apps, neuropsychological testing, and clinical assessments

Interventions

  • Diagnostic testcustom-created apps, neuropsychological testing, and clinical assessments

    This study's interventions will include a brief neuropsychological assessment, including pre-operative baseline and post-operative repeat assessment. Additional assessments of memory and coordination using two custom apps and standard clinical assessments will also be conducted at each timepoint

06

What researchers measure

Primary outcomes

  1. Standardized neuropsychiatric testing WAIS SCWT SPWT TOPJ

    comparison of results to baseline measurements of these four validated neuropsychiatric assessments

    Time frame: 24 hours

Secondary outcomes

  1. Memory App

    Use of a colored sequence presentation memory app to assess subjects return to baseline

    Time frame: 24 hours

  2. Flight Path App

    Seated subject follows the flight path of a bird on an iPad app. Comparisons made to baseline performance.

    Time frame: 24 hours

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Start is estimated for Oct 2026; primary completion for Apr 2031, 53 months later.

Start moved once since we started tracking on Sep 25, 2026: May 2026 → Oct 2026, on Oct 9, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Mar 20, 2026
First posted
May 14, 2026
StartEst.
Oct 15, 2026was May 2026
Primary completionEst.
Apr 1, 2031
CompletionEst.
Apr 1, 2032
Last update
Oct 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
May 1, 2026→Oct 15, 2026
Oct 9, 2026
Show all 1 update
  1. Oct 9, 2026
    Start date May 1, 2026→Oct 15, 2026
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07588542
Responsible party
David Glick (Department Head Ronald F Albrecht Professor of Anesthesiology; Physician/Surgeon; Chief of Service Department of Anesthesiology, University of Illinois at Chicago) — Principal investigator
First posted
May 14, 2026
Start date
Oct 15, 2026 (estimated)
Primary completion
Apr 1, 2031 (estimated)
Completion
Apr 1, 2032 (estimated)
Last update
Oct 9, 2026

Study contacts

Alexandra Barabanova
Contact
barabano@uic.edu
312-355-5377

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion